VHL Vitasora Health Limited
—Mkt Cap: —P/E: —1d ago
Vitasora Health Limited engages in the research, development, and commercialization of medical devices in Australia and the United States. The company offers wheezo device. It is also involved in the production of mobile…
Industry Peers
Health Information Services$50.68BUSDP/E 52.1
$12.83BUSD
$12.34BUSDP/E 55.2
$8.47BUSDP/E 34.6
$7.65BUSDP/E 33.5
$5.61BUSDP/E 37.1
$5.41BUSDP/E 39.2
$4.43BUSD
$2.89BUSDP/E 107.7
$1.91BUSD
$1.64BUSDP/E 43.8
$1.47BUSD
$1.20BUSDP/E 70.1
$1.14BUSDP/E 77.8
$1.08BUSD
$1.03BUSDP/E 46.9
$685.26MUSDP/E 64.9
$620.58MUSD
$594.53MUSD
$580.72MUSDP/E 31.4
Key Statistics
Company
Market Cap—
Enterprise Value18.89M USD
Revenue (TTM)3.34M USD
Gross Profit2.94M USD
Net Income (TTM)-7.33M USD
Revenue/Share0.0030 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryHealth Information Services
ISINAU0000392748
Valuation
P/E (Trailing)—
P/E (Forward)-13.00
PEG—
EV/EBITDA-2.92
EV/Revenue5.65
P/S6.31
P/B1.86
EPS (TTM)-0.01
EPS (Forward)-0.00
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin88.02%
Oper. Margin-275.42%
EBITDA Margin-193.34%
Profit Margin-219.22%
ROE-70.25%
ROA-36.19%
Growth
Revenue Growth-7.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.91M USD
CapEx (TTM)—
FCF Margin-133.74%
FCF Yield—
Net Debt-2.13M USD
Net Debt/EBITDA0.33
Balance Sheet
Debt/Equity0.00
Current Ratio2.90
Quick Ratio1.79
Book Value/Sh0.0070 AUD
Cash/Share0.0010 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJul 31, 2012
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.35B
Float1.60B
Insiders29.50%
Institutions8.94%
Technical
SMA 500.0128 AUD
SMA 2000.0162 AUD
Beta-0.32
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)906.92K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—